Cargando…
Limosilactobacillus fermentum MG4294 and Lactiplantibacillus plantarum MG5289 Ameliorates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Mice
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and the leading cause of liver-related deaths worldwide. It has been established that microorganisms are involved in the interaction between the intestinal lumen and the liver; therefore, studies on probiotics as potential ca...
Autores principales: | Lee, Ji Yeon, An, Minju, Heo, Huijin, Park, Jeong-Yong, Lee, Junsoo, Kang, Chang-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143775/ https://www.ncbi.nlm.nih.gov/pubmed/37111223 http://dx.doi.org/10.3390/nu15082005 |
Ejemplares similares
-
Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice
por: Kim, Ji Eun, et al.
Publicado: (2022) -
Limosilactobacillus fermentum MG7011: An Amylase and Phytase Producing Starter for the Preparation of Rice-Based Probiotic Beverages
por: Jo, Yu Mi, et al.
Publicado: (2021) -
Lactiplantibacillus plantarum MG4296 and Lacticaseibacillus paracasei MG5012 Ameliorates Insulin Resistance in Palmitic Acid-Induced HepG2 Cells and High Fat Diet-Induced Mice
por: Won, Gayeong, et al.
Publicado: (2021) -
Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
por: Cho, Young Gyu, et al.
Publicado: (2022) -
Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights
por: Rodríguez-Sojo, María Jesús, et al.
Publicado: (2021)